Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Climate change emotions, perceived mental health impacts, and supports among adolescents in Dhaka, Bangladesh: A cross-sectional mixed methods exploratory study.
(2026 Jan-Feb)
J Clim Chang Health 27(): 100611
Treble M, Martin G, Faulkner V, Akhtar TN, Cosma A, Roswell T, Ali HM

Communicating Confidence in the Reliability of Micro- and Nanoplastic Identification in Human Health Studies.
(2026 May 15)
Environ Health (Wash) 4(5): 804-811
Thomas KV, Belz S, Booth AM, Clift MJD, Cross RK, Davies G, Dirven H, Dunlop S, Gomiero A, Guo S, Herzke D, Koelmans AA, Mudway IS, Okoffo ED, Rauert C, Samanipour S, Symeonides C, Walker DI, Wang T, Wright SL, Xu JL, Barron LP

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses.
(2026)
Front Immunol 17(): 1798542
Shebbo S, Mahmoud DE, Alateyah N, Hosseini SH, Al-Haidose A, Ramirez SA, Zeidan A, Abdallah AM

The metabolic code of pulmonary disease: from mechanisms to therapeutic opportunities.
(2026 Apr)
Breathe (Sheff) 22(2): 250260
Kearney E, Tan SY, Wang Z, Dowling CM

Molecules in pulmonary medicine.
(2026 Apr)
Breathe (Sheff) 22(2): 260122
Sulaiman I

Show complete publication list

In the News